Actual patient treated with JUVÉDERM® VOLUX® XC in the jawline and JUVÉDERM® VOLUMA® XC in the cheeks and chin. Results may vary. Advancements in aesthetic procedures have enabled us to achieve ...

Please provide your email address to receive an email when new articles are posted on . Allergan announced it has received FDA approval to market Juvederm Ultra XC for injection into the lips and ...

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE:AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLUMA™ XC, the ...

This marks the first time that a hyaluronic acid dermal filler has received FDA approval for temple hollowing. Allergan Aesthetics, an AbbVie company, announced that the FDA has approved Juvéderm ...

Add Yahoo as a preferred source to see more of our stories on Google. Juvéderm Voluma XC, one of several hyaluronic acid-based injectables under Allergan's umbrella of Juvéderm fillers, has been a ...

JUVÉDERM® VOLUX™ XC IS THE FIRST AND ONLY HYALURONIC ACID (HA) FILLER TO RECEIVE U.S. FDA APPROVAL FOR IMPROVING JAWLINE DEFINITION IRVINE, Calif., Aug. 3, 2022 /PRNewswire/ -- Today, Allergan ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved marketing Juvéderm Vollure XC for correcting moderate-to-severe wrinkles and folds, such as ...

The FINANCIAL — Allergan plc, on June 1 announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLBELLA XC, for use in the lips for lip ...